Relation Between Hemoglobin Level and Recurrent Myocardial Ischemia in Acute Coronary Syndromes Detected by Continuous Electrocardiographic Monitoring

被引:35
作者
Rousseau, Melissa [1 ,2 ]
Yan, Raymond T. [1 ,2 ]
Tan, Mary [3 ]
Lefkowitz, Charles J. [2 ,4 ]
Casanova, Amparo [3 ]
Fitchett, David [1 ,2 ,3 ]
Jolly, Sanjit S. [5 ]
Langer, Anatoly [2 ,3 ]
Goodman, Shaun G. [1 ,2 ,3 ]
Yan, Andrew T. [1 ,2 ,3 ]
机构
[1] St Michaels Hosp, Div Cardiol, Toronto, ON M5B 1W8, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Canadian Heart Res Ctr, Toronto, ON, Canada
[4] Toronto E Gen & Orthopaed Hosp, Toronto, ON, Canada
[5] McMaster Univ, Dept Med, Populat Hlth Res Inst, Hamilton, ON, Canada
关键词
HIGH-RISK; PROGNOSTIC-SIGNIFICANCE; CLINICAL-OUTCOMES; BLOOD-TRANSFUSION; 30-DAY MORTALITY; OXYGEN DELIVERY; INFARCTION; ANEMIA; DISEASE; EVENTS;
D O I
10.1016/j.amjcard.2010.07.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anemia has been associated with adverse outcomes in patients with acute coronary syndromes (ACS). However, the underlying pathophysiologic mechanisms have not been well elucidated. We sought to determine the independent relation between the hemoglobin level and recurrent ischemia in patients with non-ST-segment elevation ACS using continuous electrocardiographic monitoring. In the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial, 746 patients presenting with non-ST-segment elevation ACS underwent continuous ST-segment monitoring for 48 hours. The data were analyzed independently at a core laboratory. We stratified the study population according to their hemoglobin level on presentation. The primary outcome of the study was recurrent ischemia, defined as ST-segment shifts on continuous electrocardiographic monitoring. Of the 705 patients with analyzable data, 64 had a baseline hemoglobin level < 120 g/L, 259 had a level of 120 to 139 g/L, 315 had a level of 140 to 159 g/L, and 67 had a level > 160 g/L. The corresponding rates of recurrent ischemia were 39.1%, 22.0%, 15.6%, and 11.9% (p for trend < 0.001). A lower hemoglobin level was associated with advanced age, co-morbidities, and a higher GRACE risk score. In multivariable analysis adjusting for these confounders, lower hemoglobin levels retained a significant independent association with recurrent ischemia (p for trend = 0.004). In conclusion, a lower hemoglobin level at presentation was independently associated with recurrent ischemia detected by continuous electrocardiographic monitoring in the setting of non-ST-segment elevation ACS. This suggests that anemia might predispose patients to recurrent ischemia, which could be an important underlying mediator of worse outcomes in patients with lower hemoglobin levels. (C) 2010 Elsevier Inc. All rights reserved. (Am J Cardiol 2010;106:1417-1422)
引用
收藏
页码:1417 / 1422
页数:6
相关论文
共 30 条
[1]   Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events - Meta-analysis of three studies involving 995 patients [J].
Akkerhuis, KM ;
Klootwijk, PAJ ;
Lindeboom, W ;
Umans, VAWM ;
Meij, S ;
Kint, PP ;
Simoons, ML .
EUROPEAN HEART JOURNAL, 2001, 22 (21) :1997-2006
[2]   Heart failure and anemia: mechanisms and pathophysiology [J].
Anand, Inder S. .
HEART FAILURE REVIEWS, 2008, 13 (04) :379-386
[3]   Acute coronary syndromes in the GUSTO-IIb trial - Prognostic insights and impact of recurrent ischemia [J].
Armstrong, PW ;
Fu, YL ;
Chang, WC ;
Topol, EJ ;
Granger, CB ;
Betriu, A ;
Van de Werf, F ;
Lee, KL ;
Califf, RM .
CIRCULATION, 1998, 98 (18) :1860-1868
[4]   EARLY POSTINFARCTION ISCHEMIA - CLINICAL, ANGIOGRAPHIC, AND PROGNOSTIC-SIGNIFICANCE [J].
BOSCH, X ;
THEROUX, P ;
WATERS, DD ;
PELLETIER, GB ;
ROY, D .
CIRCULATION, 1987, 75 (05) :988-995
[5]   Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy [J].
Cohen, M ;
Stinnett, SS ;
Weatherley, BD ;
Gurfinkel, EP ;
Fromell, GJ ;
Goodman, SG ;
Fox, KAA ;
Califf, RM .
AMERICAN HEART JOURNAL, 2000, 139 (06) :962-970
[6]   Bleeding complications in patients with anemia and acute myocardial infarction [J].
Dauerman, HL ;
Lessard, D ;
Yarzebski, J ;
Gore, JM ;
Goldberg, RJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (10) :1379-1383
[7]   Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction:: The Canadian ESSENCE ST segment monitoring substudy [J].
Goodman, SG ;
Barr, A ;
Sobtchouk, A ;
Cohen, M ;
Fromell, GJ ;
Laperrière, L ;
Hill, C ;
Langer, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (05) :1507-1513
[8]   Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide [J].
Goodman, SG ;
Fitchett, D ;
Armstrong, PW ;
Tan, M ;
Langer, A .
CIRCULATION, 2003, 107 (02) :238-244
[9]   SILENT ISCHEMIA ON HOLTER MONITORING PREDICTS MORTALITY IN HIGH-RISK POSTINFARCTION PATIENTS [J].
GOTTLIEB, SO ;
GOTTLIEB, SH ;
ACHUFF, SC ;
BAUMGARDNER, R ;
MELLITS, ED ;
WEISFELDT, ML ;
GERSTENBLITH, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (07) :1030-1035
[10]   Predictors of hospital mortality in the global registry of acute coronary events [J].
Granger, CB ;
Goldberg, RJ ;
Dabbous, O ;
Pieper, KS ;
Eagle, KA ;
Cannon, CP ;
Van de Werf, F ;
Avezum, A ;
Goodman, SG ;
Flather, MD ;
Fox, KAA .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (19) :2345-2353